Noninfectious interstitial lung disease during infliximab therapy: Case report and literature review

doi:10.3748/wjg.v19.i32.5377

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 32

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6480)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

485

HTML

3516

Figures (1-1)

221

Tables (1-2)

219

Sum=4441

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1029

Download

1010

Sum=2039

Aug 28, 2013 (publication date) through Jan 10, 2025

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Aug 28, 2013; 19(32): 5377-5380
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5377

Table 1 Analysis of the bronchoalveolar lavage fluid

	Cells (10⁶/L)	Macrophages	Lymphocytes	Neutrophils	Eosinophils
Patient	213	66%	13%	1%	20%
Ref. values	120-190	85%-93%¹	5%-12%¹	2%¹	< 1%¹

¹According to Meyer[16].

Citation: Caccaro R, Savarino E, D’Incà R, Sturniolo GC. Noninfectious interstitial lung disease during infliximab therapy: Case report and literature review. World J Gastroenterol 2013; 19(32): 5377-5380
URL: https://www.wjgnet.com/1007-9327/full/v19/i32/5377.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i32.5377